Debra J Ehrlich, M.D.
National Institute of Neurological Disorders and Stroke (NINDS)
11
11
3
N/A
0
32
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (11)
Showing 10 of 11 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Mark Hallett, M.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Shared therapeutic areas:
Worked with same sponsors:
Robert B Innis, M.D.
National Institute of Mental Health (NIMH)
Shared therapeutic areas:
Muhammad Kashif
Riphah International University
Shared therapeutic areas:
Anissa MEGZARI
Centre Hospitalier Universitaire de Nīmes
Shared therapeutic areas:
Paolo Bonato, PhD
Spaulding Rehabilitation Hospital
Shared therapeutic areas:
Herbert B Slade, MD
Healthpoint
Shared therapeutic areas:
Hagop Youssoufian, MD
Verastem, Inc.
Shared therapeutic areas:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Suman Sheraz, PhD*
Riphah International University
Shared therapeutic areas:
Urielle Desalbres
Assistance Publique Hôpitaux de Marseille
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (11)
Showing 11 of 11 trials
Natural History Protocol for Movement Disorders
Non-invasive Intermittent Theta Burst Stimulation of the Dorsolateral Prefrontal Cortex in Functional Movement Disorders
Acute Effects of Medium Chain Triglyceride (MCT) Nutritional Ketosis on Parkinson's Disease (PD) Symptoms and Biomarkers (MCT-PD)
Deep Brain Stimulation Surgery for Focal Hand Dystonia
Clinical and Physiological Studies of Tremor Syndromes
Deep Brain Stimulation Therapy in Movement Disorders
Phenotype/Genotype Correlations in Movement Disorders
Diagnosis and History Study of Patients With Different Neurological Conditions
Botulinum Toxin for the Treatment of Involuntary Movement Disorders
Distinguishing Tics and Functional Tics Using Clinical Neurophysiological Techniques
Longitudinal Natural History Protocol for PRKN- and PINK1-Linked PD
All 11 trials loaded